Creeping eruption of the hand in an Iranian patient: Cutaneous larva migrans


1 Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Student Reserch Committee (SRC), School of Medicine, Semnan University of Medical Sciences, Semnan, Iran

3 Department of Infectious Diseases, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran


Cutaneous larva migrans (CLM), a serpiginous cutaneous eruption is the most commonly acquired tropical dermatosis. It is caused by infection with hookworm larvae in tropical and sub-tropical areas, and people who have a history of travel in these countries. The most frequent location of CLM is the distal lower extremities or buttocks. We describe a case of 57-year-old Iranian female patient with CLM of hand (unusual site) without traveling to endemic countries that was successfully treated with oral albendazole. To the best of our knowledge, this is the first report of CLM in Iran.


Lee R. Case of creeping eruption. Trans Clin Soc Lond 1874;8:44-5.  Back to cited text no. 1
Davies HD, Sakuls P Keystone JS. Creeping eruption. A review of clinical presentation and management of 60 cases presenting to a tropical disease unit. Arch Dermatol 1993; 129:528-529.  Back to cited text no. 2
Karthikeyan K, Thappa DM. Cutaneous larva migrans. Indian J Dermatol Venereol Leprol 2002;68:252-8.  Back to cited text no. 3
[PUBMED]  Medknow Journal  
Heukelbach J, Feldmeier H. Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans. Lancet Infect Dis 2008;8:302-9.  Back to cited text no. 4
Blackwell V, Vega-Lopez F. Cutaneous larva migrans: Clinical features and management of 44 cases presenting in the returning traveller. Br J Dermatol 2001;145:434-7.  Back to cited text no. 5
Brenner MA, Patel MB. Cutaneous larva migrans: The creeping eruption. Cutis 2003;72:111-5.  Back to cited text no. 6
Caumes E. Treatment of cutaneous larva migrans. Clin Infect Dis 2000;30:811-4.  Back to cited text no. 7
Van den Enden E, Stevens A, Van Gompel A. Treatment of cutaneous larva migrans. N Engl J Med 1998;339:1246-7.  Back to cited text no. 8
Coulaud JP, Binet D, Voyer C, Samson C, Moreau G, Rossignol JF. Treatment of the cutaneous larva migrans syndrome "Larbish" with albendazole. Apropos of 18 cases. Bull Soc Pathol Exot Filiales 1982;75:534-7.  Back to cited text no. 9
Caumes E, Carriere J, Datry A, Gaxotte P, Danis M, Gentilini M. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 1993;49:641-4.  Back to cited text no. 10
Kim TH, Lee BS, Sohn WM. Three clinical cases of cutaneous larva migrans. Korean J Parasitol 2006;44:145-9.  Back to cited text no. 11
Bava J, Gonzalez LG, Seley CM, López GP, Troncoso A. A case report of cutaneous larva migrans in Argentina. Asian Pac J Trop Biomed 2011;1:81-2.  Back to cited text no. 12
Veraldi S, Bottini S, Rizzitelli G, Persico MC. One-week therapy with oral albendazole in hookworm-related cutaneous larva migrans: A retrospective study on 78 patients. J Dermatolog Treat 2012;23:189-91.  Back to cited text no. 13